Contrasting short-term temperature effects on the profiling of metabolic and stress hormones in non-obese healthy adults: A randomized cross-over trial

https://doi.org/10.1016/j.envres.2019.109065Get rights and content

Highlights

  • There is limited evidence about the effect of elevated air temperatures, as a result of climate change, on metabolic health.

  • We show beneficial alterations in leptin levels for urban dwellers during their short-term stay in a climate-cooler setting.

  • A positive association was observed between personal skin temperatures and leptin or adiponectin levels.

Abstract

The manifestation of elevated and sustained air temperature gradient profiles in urban dwellings represents an emerging planetary health phenomenon. There is currently limited evidence about the effect of elevated air temperatures on metabolic health. The aim of this work was to assess changes in metabolic and stress hormonal profiles during a short-term stay in a mountainous, climate-cooler setting against those observed in the urban setting. A prospective, randomized, 2 x 2 cross-over trial of non-obese healthy adults in urban and mountainous areas of a Mediterranean country (Cyprus) was set up during summer, under real-life conditions. The intervention was a short-term stay (mean ± SD: 7 ± 3 days) in a mountainous, climate-cooler setting (altitude range: 650–1200 m), being ~1-h drive away from the main urban centres of Cyprus. The primary endpoint was the change in metabolic hormones levels (leptin and adiponectin) and stress hormone levels (cortisol) between the two settings. Personal air and skin temperature sensors were deployed while biospecimen were collected in each setting. A total of 41 participants between 20 and 60 years old were enrolled and randomized during July 2018, of whom 39 received the allocated intervention, 8 were lost to follow up or excluded from analysis and a total of 31 participants were analysed. A significant leptin reduction (β = −0.255; 95% CI: −0.472, −0.038; p = 0.024) was observed for non-obese healthy adults during their short-term stay in the mountainous environment. The intervention effect on adiponectin or cortisol levels was not statistically significant (β = 0.058; 95% CI: −0.237, 0.353; p = 0.702), and (β = −0.026; 95% CI: −0.530, 0.478; p = 0.920), respectively. In additional analyses, daily max skin temperature surrogate measures were significantly associated with leptin levels (β = 0.34; 95% CI: 0.051, 0.633; p = 0.024). During summer season, a short-term stay in climatologically cooler areas improved the leptin levels of non-obese healthy adults who permanently reside in urban areas of a Mediterranean country. A larger sample is needed to confirm the trial findings that could provide the rationale for such public health interventions in climate-impacted urban areas of our planet.

Introduction

The World Health Organisation recognises the overall health impacts of a changing climate as overwhelmingly negative (World Health Organization, 2017). Seasonal, long-sustained high temperature weather conditions appear to have a direct impact on human health by affecting the body's ability to regulate its internal temperature (Hajat et al., 2017; Hanna and McIver, 2018; Sarofim et al., 2016; Vardoulakis and Heaviside, 2012; Yang et al., 2014). The direct health impacts of exposure to heat are often assessed in terms of mortality risk (Gasparrini et al., 2015), including cardiovascular, respiratory, renal and infectious diseases, and neurological/psychiatric disorders (Basagaña et al., 2011; Xu et al., 2012; Åström et al., 2011; Checkley et al., 2009).

Evidence of community or regional measures to assess heat effects consist primarily of observational studies conducted in the US and Europe (White-Newsome et al., 2014; Lim and Spanger-Seigfried, 2004). Population vulnerability is defined on the basis of three components, namely, the exposure level, the extent of susceptibility and the adaptive capacity (Michelozzi et al., 2014). Groups of elderly people and individuals with impaired health status may be particularly vulnerable to climate change manifestations of higher temperatures, as they have diminished ability to thermo-regulate body core temperature, thus increasing medical co-morbidities or use of medications, while the social position of an individual could modify the extent of behavioural adjustments to sustained high temperatures (Bennett et al., 2014; Ishigami et al., 2008).

Earlier observational studies demonstrated the effect of heat stress on the cognitive function of elderly (mean age of 73 yrs old) using repeated measures of residential air temperature records (Gasparrini et al., 2015; Dai et al., 2016). Apart from clinical effects, excessive heat could adversely influence human performance and work capacity (Kjellstrom et al., 2009, 2016), or performance in exercise/sports (Brotherhood, 2008). Recently, the relationship between indoor environmental conditions, heat exposures, sleep and cognitive function was examined among young adults living in centrally-controlled air conditioned (AC) and non-AC residence halls on a university campus (Cedeño Laurent et al., 2018); authors found that students living in non-AC spaces during a heat wave in Boston experienced significant decrements on cognitive performance tests (reaction time, throughput, 2-digit visual addition/subtraction test) relative to AC residents at baseline (Cedeño Laurent et al., 2018).

There is currently limited evidence about the effect of elevated ambient air temperatures on metabolic outcomes. An experimental study showed that the adapted thermogenesis process was reduced in temperatures within the thermal comfort zone of the human being, while colder air exposures increased thermogenesis from the brown adipose tissue (BAT) and energy expenditure processes, resulting in lower body weight (Turner et al., 2016). Some evidence also exists about the increasing ambient temperature effects on age adjusted type II diabetes incidence rates in the US, however, these were premature results (ecological study) (Lee et al., 2014). Another experimental study conducted under well controlled conditions (n = 5) showed that a small elevation in ambient temperature (reaching 27 °C, for a month duration) increased leptin and decreased adiponectin levels (Blauw et al., 2017).

Therefore, the design and testing of cost-effective and sustainable health interventions for the public against the detrimental manifestations of climate change and hot weather are of paramount importance. We designed a pilot experimental trial (TEMP trial) in real-life conditions that examined changes in metabolic and stress hormonal profiles of healthy, non-obese adults in two study settings with distinctly different climatological characteristics: urban vs. higher in altitude (range: 650–1200 m, mean ± SD: 881 ± 200 m) mountainous setting (being 1-h away driving from main urban centres of Cyprus). In addition, the trial examined the relationship between personal air and skin temperatures and adipokines (leptin and adiponectin) between the urban and rural settings.

Section snippets

Trial oversight

The TEMP trial was a 2 x 2 cross-over pilot trial of healthy, non-obese adults (n = 41). The trial was conducted under real-life conditions (instead of controlled environment) to examine the effect of setting and personal ambient/skin temperature gradient on metabolic hormones levels (Fig. 1). Eligible participants were those who met the following criteria: healthy, non-obese adults between 20 and 60 years old having their permanent primary residence in one of the two largest cities of Cyprus

Participant characteristics

A total of 41 subjects were recruited and agreed to participate; and upon house visit, 2 of them declined participation (Fig. 2). During follow-up, 3 participants were excluded, since they only provided urinary samples in one of the two settings. During analysis, 5 additional participants were excluded, because exclusion criteria applied following questionnaires digitization [obese status (n = 3) and ongoing thyroxin treatment (n = 1)] and because of abnormally high leptin levels in all four

Discussion

Extending the work published in other hyperthermia human studies, and to the best of our knowledge, this is the first, 2 x 2 prospective, randomized, cross-over, non-pharmacological trial that investigated the alterations of metabolic and stress hormones associated with a short-term stay (mean duration of 7 days) in climatologically cooler areas than those observed in geographically adjacent urban settings (~1-h driving distance). A robust significant leptin reduction (p = 0.024) during the

Contributors

KCM conceived, designed and coordinated the trial. AP, CK and KCM conducted the field work and data collection. CK conducted the sample analyses. CK executed the primary data analysis and ABZ the secondary analysis, both with guidance from KCM and CAC. All authors interpreted the results and drafted the manuscript. KCM obtained internal funding. All authors revised the article for important intellectual content. KCM is the principal investigator and guarantor of the study.

Declaration of competing interest

No competing interests: All authors declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Transparency declaration

The manuscript's guarantor affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as originally planned (and, if relevant, registered) have been explained.

Financial disclosure - role of the funding source

Internal funds of the principal investigator (KC Makris) were used for this study. No external funding was obtained for this study. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Data sharing

The authors commit to making the relevant anonymized patient level data available via open access.

Acknowledgments

We sincerely thank all TEMP trial participants for their willingness to participate in the study. We greatly acknowledge Mrs. Chrystalla Oikonomidou for the field work collecting the data in the field. We also thank Dr. Pantelis Charisiadis for the cortisol analyses.

References (38)

  • L.L. Blauw et al.

    Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature

    BMJ Open Diabetes Res and Care

    (2017)
  • J.G. Cedeño Laurent et al.

    Reduced cognitive function during a heat wave among residents of non-air-conditioned buildings: an observational study of young adults in the summer of 2016

    PLoS Med.

    (2018)
  • W. Checkley et al.

    Short-term weather variability in Chicago and hospitalizations for Kawasaki disease

    Epidemiology

    (2009)
  • M. Fontes-Villalba et al.

    Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial

    Cardiovasc. Diabetol.

    (2016)
  • K. Ghoshal et al.

    Adiponectin: probe of the molecular paradigm associating diabetes and obesity

    World J. Diabetes

    (2015)
  • S. Hajat et al.

    The effect of ambient temperature on type-2-diabetes: case-crossover analysis of 4+ million GP consultations across England

    Environ. Health

    (2017)
  • E.G. Hanna et al.

    Climate change: a brief overview of the science and health impacts for Australia

    Med. J. Aust.

    (2018)
  • M. Hibi et al.

    Effect of shortened sleep on energy expenditure, core body temperature, and appetite: a human randomised crossover trial

    Sci. Rep.

    (2017)
  • A. Ishigami et al.

    An ecological time-series study of heat-related mortality in three European cities

    Environ. Health

    (2008)
  • Cited by (5)

    View full text